SAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) — The law firm of Robbins Geller Rudman & Dowd LLP<\/strong><\/a> announces that the Organon <\/em>class action lawsuit \u2013 captioned Hauser v. Organon & Co.<\/em>, No. 25-cv-05322 (D.N.J.) \u2013 seeks to represent purchasers or acquirers of Organon & Co. (NYSE: OGN) securities and charges Organon as well as certain of Organon\u2019s top executives with violations of the Securities Exchange Act of 1934.<\/p>\n If you suffered substantial losses and wish to serve as lead plaintiff of the <\/strong>Organon <\/em><\/strong>class action lawsuit, please provide your information here:<\/strong><\/p>\n https:\/\/www.rgrdlaw.com\/cases-organon-co-class-action-lawsuit-ogn.html<\/strong><\/a><\/p>\n You can also contact attorneys <\/strong>J.C. Sanchez<\/strong><\/a> or <\/strong>Jennifer N. Caringal<\/strong><\/a> of Robbins Geller by calling 800\/449-4900 or via e-mail at <\/strong>info@rgrdlaw.com<\/strong><\/a>. Lead plaintiff motions for the <\/strong>Organon <\/em><\/strong>class action lawsuit must be filed with the court no later than Tuesday, July 22, 2025.<\/strong><\/p>\n CASE ALLEGATIONS<\/strong>: Organon develops and delivers health solutions through prescription therapies and medical devices.<\/p>\n The Organon<\/em> class action lawsuit alleges that defendants throughout the class period made false and\/or misleading statements and\/or failed to disclose that: (i) defendants concealed material information pertaining to Organon\u2019s capital allocation priorities, particularly the future of the quarterly dividend payout; (ii) in truth, Organon\u2019s optimistic reports of the dividend payout as Organon\u2019s \u201cnumber one priority\u201d were offset by Organon\u2019s newly implemented debt reduction strategy, thus, leading to a drastic decrease \u2013 over 70% \u2013 of the quarterly dividend; and (iii) Organon planned to prioritize debt reduction following Organon\u2019s acquisition of Dermavant Sciences Ltd.<\/p>\n The Organon<\/em> class action lawsuit further alleges that on May 1, 2025, Organon reported first quarter 2025 financial results and announced that management reset Organon\u2019s dividend payout from $0.28 to $0.02. On this news, the price of Organon stock fell more than 27%, according to the complaint.<\/p>\n THE LEAD PLAINTIFF PROCESS<\/strong>: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Organon securities during the class period to seek appointment as lead plaintiff in the Organon <\/em>class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Organon <\/em>class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Organon <\/em>class action lawsuit. An investor\u2019s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Organon <\/em>class action lawsuit.<\/p>\n ABOUT ROBBINS GELLER<\/strong>: Robbins Geller Rudman & Dowd LLP is one of the world\u2019s leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases \u2013 more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs\u2019 firms in the world, and the Firm\u2019s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever \u2013 $7.2 billion \u2013 in In re Enron Corp. Sec. Litig.<\/em> Please visit the following page for more information:<\/p>\n
![\"\"](\"https:\/\/ml.globenewswire.com\/media\/NjU5OTgzYmMtMDVmZS00ODQzLWJmMzQtMTIxOWViOTZhYzllLTExNDgxNTAtMjAyNS0wNi0yOC1lbg==\/tiny\/Robbins-Geller-Rudman-Dowd-LLP.png\")
\n <\/div>\n","protected":false},"excerpt":{"rendered":"